Introduction
Prostate cancer is considered to be the most common solid tumour malignancy in men. 1 According to the American Cancer Society estimates for the number of new cancer cases and deaths in the United States in 2011, prostate cancer accounted for 29% of all newly diagnosed cancers among men. 2 Prostate cancer surpassed colorectal cancer as the second most common cause of cancer death among men aged ≥ 80 years. 2 Improved understanding of the molecular mechanisms responsible for the onset of prostate cancer, and early detection during cancer progression, have become very important for therapeutic intervention. The Gleason grading system, proposed by Dr Donald F Gleason in 1966, is a key histopathological predictor of prognosis for patients with prostate cancer. 3 Its introduction enabled patients and physicians to make more-informed treatment decisions based on the probability of a pathological stage, risk tolerance and the likelihood of various potential outcomes. 4 The grade (Gleason score), cancer stage, extent of the KEY WORDS: PROSTATE CANCER; GLEASON SCORE; MITOCHONDRIAL FUNCTIONAL SCORE a X Sun, N-K Liao and J-J Yu contributed equally to this article.
X Sun, N-K Liao, J-J Yu Mitochondrial functional score in prostate cancer tumour and serum prostate specific antigen level are closely correlated in the Gleason system, and characterize the difference between low-and high-grade malignancy of prostate carcinoma.
A considerable amount of published and ongoing research has been devoted to the role of mitochondrial dysfunction in cancer. Somatic mutations of mitochondrial DNA (mtDNA) are increasingly recognized in human cancers such as pancreatic cancers and pilocytic astrocytoma tumours. 5, 6 Some studies indicate that mtDNA mutations can contribute to tumour progression by enhancing the metastatic potential of tumour cells. 7 Mitochondrial dysfunction generally exists in patients with prostate cancer. 8 Thus, mtDNA may have the potential to be a clinically useful biomarker for the early detection of prostate cancer. The role of mutations in mtDNA in contributing to the progression of prostate cancer, and whether this can be evaluated through changes in mitochondrial structure, requires further study. To address this issue, the present study examined the correlation between the Gleason score and the mitochondrial functional scores in patients with prostate cancer, in order to determine the role of the mitochondrial functional score in predicting the progression of prostate cancer.
Patients and methods

STUDY POPULATION
Consecutive patients who had undergone radical prostatectomy for clinically localized prostate cancers at the Affiliated Hospital of Shanghai Jiao Tong University, Shanghai, China, between October 2006 and March 2007, were included in this retrospective study. None of the included patients had received preoperative hormonal or radiation therapy. There were no other inclusion or exclusion criteria for the study. One year follow-up was performed by telephone. Mortality was calculated from the date of surgery to death, and only cancer-related deaths were recorded.
The study protocol was approved by the Ethics Review Committee of Shanghai Jiao Tong University. The patients participating in the study provided verbal informed consent.
EVALUATION OF GLEASON SCORE
Prostate tumour tissue specimens from the radical prostatectomy were fixed immediately for 24 -36 h in 4% formaldehyde, and then processed according to a modified Stanford method. 9 Every specimen was embedded in paraffin and 3µm sections were prepared and stained with haematoxylin and eosin, and examined by low-light microscopy at × 40 magnification. All the prostate cancer scores were assessed by the same pathologist according to the modified Gleason system, 10 and then the patients were divided into six groups (groups 1 -6) according to Gleason score (Gleason scores 2 -7, respectively). A higher Gleason score indicated a more aggressive cancer.
EVALUATION OF MITOCHONDRIAL FUNCTIONAL SCORE
Prostate tumour tissue specimens from the radical prostatectomy were fixed using 2.5% glutaraldehyde in 0.1 M phosphate-buffered saline (PBS), pH 7.4, for 2 h. After washing with 0.1 M PBS, the tissues were postfixed with 1% osmium tetroxide for 1.5 h and washed again with 0.1 M PBS. Tissues were dehydrated in ascending grades of acetone and embedded in epoxy resin. After resin polymerization, ultrathin sections of approximately 50 nm were cut and doublestained with uranyl acetate and lead citrate. These sections were mounted on aluminium X Sun, N-K Liao, J-J Yu Mitochondrial functional score in prostate cancer electron microscope grids and coated in carbon, and 200 mitochondria were randomly observed in each specimen by OLYMPUS transmission electron microscopy (KeenView G2 TEM CCD, Olympus Optical Co., Tokyo, Japan). Systematic counts of mitochondria were performed.
The ultrastructural changes in the mitochondria were assessed by means of semiquantitative evaluation. 11 For this purpose, the mitochondria were classified according to the following Flameng mitochondrial functional scoring system on a scale of 1 -5: 5, the structure of the mitochondria remained intact and filled with granules; 4, the structure of the mitochondria remained intact, but the mitochondrial granules were absent; 3, mitochondrial swelling and matrix clearing had occurred; 2, the mitochondrial cristae were broken and matrix clearing and concentrating were visible; 1, the mitochondrial cristae were broken and the intact mitochondrial membranes had disappeared.
STATISTICAL ANALYSES
Statistical analyses were performed using SAS ® software, version 9.1.3 (SAS Institute, Cary, NC) for Windows ® . The results were expressed as mean values ± SE. Statistical comparisons were carried out using Student's t-test. Correlations between the Gleason grade and the mitochondrial functional score were examined using Pearson's correlation coefficient. A P-value < 0.05 was considered to be statistically significant.
Results
A total of 72 patients, aged between 58 and 79 years (mean ± SE 70.1 ± 1.2 years), were included in the study. At 1-year follow-up, significantly fewer patients in group 1 (Gleason score 2) than in group 6 (Gleason score 7) had died: 0/15 patients versus 2/10 patients, respectively (P < 0.05).
As shown in Table 1 , the mean mitochondrial functional score was significantly lower in group 6 than in group 1 (P < 0.05). A statistically significant inverse correlation was found between the Gleason and mitochondrial functional scores (r = -0.821, P < 0.05).
Transmission electron microscopy observations showed that the mitochondria tended to be few in number in the majority of prostate cancer cells, as described previously for cancers with higher degrees of malignancy. 12 In addition, the following abnormal ultrastructural features of the Gleason scores and mitochondrial functional scores of patients (n = 72) with prostate cancer included in the present study evaluating the prognostic value of a mitochondrial functional score in predicting the progress of prostate cancer X Sun, N-K Liao, J-J Yu Mitochondrial functional score in prostate cancer mitochondria were observed: swelling, low matrix electron density, cristae that were scarce, disordered, broken or absent, and mitochondrial vacuolation (data not shown).
Discussion
Mitochondria are regarded as the powerhouse of the cell, providing up to 95% of cellular energy in the form of ATP through oxidative phosphorylation (OXPHOS). 13 In addition to producing cellular energy, mitochondria also play a role in many other important cellular functions including the regulation of intermediary metabolism, ion homeostasis, lipid and amino acid syntheses, and apoptotic and necrotic cell death. 14 Due to the importance of mitochondria in cellular functions, the role of mitochondrial dysfunction in cancer has attracted increasing attention. Studies have identified mtDNA mutations and consequential mitochondrial dysfunction associated with the progression and development of various types of human cancer, including pancreatic 6 and prostate cancer. 15 A variety of mtDNA coding and control region mutations have been reported in prostate cancer. These functionally important mtDNA mutations have been found to be more frequent in patients with prostate cancer, compared with healthy controls. 16 The effect of mtDNA dysfunction on the development of cancer may be explained in several ways. Pathogenic mtDNA mutations invariably result in a defect in mitochondrial respiratory chains, thereby reducing their ability to produce cellular ATP through OXPHOS and shift the cell's metabolism towards ATP generation by aerobic glycolysis. 17 Aerobic glycolysis is a common feature of solid tumours, and studies have reported cancer cells to have low numbers of mitochondria and to be highly glycolytic. 17 An alternative mtDNA mutation associated with the progresssion of cancer is the increased production of reactive oxygen species (ROS), which are generated as toxic by-products of mitochondrial OXPHOS. 18 Under normal physiological conditions, the body's own defence systems can remove ROS over time. When the production of ROS is excessive, or the antioxidant defence system is inhibited, mitochondrial ROS cannot be removed effectively. The ROS accumulate in the mitochondria gradually, and the mtDNA are susceptible to damage. 19 Any damage induced by ROS results in morphological changes in the mitochondria. 20, 21 The primary manifestations of damage to the mtDNA include insertions or deletions of nucleic acid fragments and base modifications. Deletions are the most common mtDNA mutations, which can accumulate with age in many tissues of the body and may be a factor in the aetiology of cancer. 22 The mtDNA mutations that inhibit OXPHOS and increase ROS production could act as both tumour promoters and tumour initiators, 18, 23 and have been demonstrated to increase prostate cancer cell growth in vivo. 16 The mitochondria are sensitive indicators of damage in prostatic epithelial cells. 24 Compared with nuclear DNA, the mitochondrial genome is extremely susceptible to damage such as that caused by increased ROS production. 25, 26 High frequency and copy numbers of mtDNA, lack of DNA-binding proteins to protect the mtDNA and lack of an effective postinjury repair system contribute towards the susceptibility of mtDNA to damage by external factors. 27 Furthermore, the replication of mtDNA is asymmetric, and spontaneous deamination events occur easily in the single-stranded DNA present during the replication process. 28, 29 Pathogenic mtDNA mutations are also thought to promote tumourigenesis by 30 During the early stages of apoptosis, mitochondria may undergo significant structural changes. Mitochondrial morphology is controlled by the processes of mitochondrial remodelling, continuous fission-fusion events and inner membrane/cristae transitions, the disruption of which can lead to mitochondrial dysfunction and affect programmed cell death. 31 Thus, it may be possible to assess changes in mitochondrial function by evaluating changes in mitochondrial structure.
The majority of prostate cancer specimens included in the present study, and analysed using transmission electron microscopy, were found to have low numbers of mitochondria with abnormal ultrastructural features: these included swelling, low matrix electron density, cristae that were scarce, disordered, broken or absent and mitochondrial vacuolation.
In conclusion, the present study supports the findings from previous studies demonstrating mitochondrial dysfunction in patients with prostate cancer, especially in the more malignant cases. Changes in mitochondrial function could be evaluated through analysing the structure of mitochondria, and the mitochondrial functional score combined with the Gleason score was beneficial for predicting the progression of prostate cancer. Further studies are needed to elucidate the role of the mitochondrial functional score in predicting the progress of prostate cancer.
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